Navigation Links
Study sees need for standardized evaluation of antibody response to HIV-1
Date:8/7/2008

U.S. Military HIV Research Program (USMHRP) researcher Victoria R. Polonis, Ph.D., and colleagues released findings on a study of cross-clade neutralization patterns among HIV-1 strains from six major clades in the 5 Jun 2008 issue of Virology.

Broadly neutralizing antibodies are likely to play a key role in any successful global vaccine for HIV. This study looked specifically at the role of clade in eliciting protective responses. Working with USMHRP colleague Francine McCuthan, Ph.D., researchers had access to a wide range of pure clade reagents, which they used to analyze the cross-clade neutralization patterns.

Another key goal of this study was to assess the impact of assay choice on the evaluation of cross-clade neutralization. The team examined the performance of different types of antibodies in both traditional primary cell neutralization assays and the newer, more standardized TZM-bl reporter cell line assays.

A major finding of the study was that the results of the two assay formats showed no direct correlation. This underscores the need to identify a physiologically relevant and standardized platform for reproducible measurement of neutralizing antibodies. Until such a product is available, researchers recommend that parallel evaluation with both platforms should be contemplated until a better understanding of immune correlates of protection is achieved.

Polonis and colleagues also found that the clade C antibody pool (from subjects infected with clade C from Tanzania) was broadly cross-reactive, neutralizing the greatest number of viruses in both assays. "The data is encouraging," noted Polonis. "Clade C vaccine products certainly warrant further investigation in light of several recent publications regarding potentially novel properties of the C envelope and because more than half of the global HIV-1 infections are clade C." In fact, Polonis and her team have an ongoing project to develop a clade C envelope subunit vaccine derived from acute infection.


'/>"/>

Contact: JoAnn Sperber
jsperber@hjf.org
301-294-1234
Henry M. Jackson Foundation for the Advancement of Military Medicine
Source:Eurekalert

Related medicine news :

1. Study Links Agent Orange to Prostate Cancer in Vietnam Vets
2. KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults
3. Alcohol consumption declining, according to results of new study
4. UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies
5. Study: verbal aggression may affect childrens behavior
6. Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought
7. First national study of diving-related injuries
8. American Cancer Society study finds high use of complementary methods among cancer survivors
9. Canadian study of colds and kids: Positive safety results for ginseng extract
10. Epilepsy drug may help alcoholics recover from dependence, small study suggests
11. Office of the Future Environment Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... ... Butler Mobility invited Ken Matthews to visit its manufacturing facility and showroom ... impressed with the safety and reliability of the Stannah Stairlift as well as with ... endorsement by Ken Matthews can be heard on News Radio WHP 580 weekdays from ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Smiles by Seese ... Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and ... under one roof. Smiles by Seese serves patients of all ages with excellence in ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, http://www.fdanews.com/deviceapproval ... asking before selecting an FDA approval pathway? , How should they evaluate ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for ... Reduction Program (HRRP), the return of a patient to the hospital within 30 days ... many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... -- Noble Capital Markets announced today that it has initiated ... EPIX ). The report was issued by Noble,s Head ... ESSA Pharmaceuticals is a clinical stage biopharmaceutical company ... lead compound EPI-506, is a small molecule oral drug ... receptor, thereby has potential to overcome some of the ...
(Date:2/16/2017)... , Feb. 16, 2017 Quest Diagnostics ... of diagnostic information services, today announced that it has ... for 2017 by Fortune. The annual ... companies in the "Health Care: Pharmacy and Other Services" ... diagnostic information services company to attain the designation. This ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company, today announced that executive management will participate ... be held February 22-23, 2017. Adrian Adams , ... Company at 1:35 p.m. local time on Wednesday, February ... archive for the event may be accessed from the ...
Breaking Medicine Technology: